Top Markets
Coin of the day
CARGO Therapeutics, Inc. Common Stock CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc. Common Stock

CRGX
Classifica tra le azioni #18093
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company... CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.
Prezzo delle azioni
$4.47
Ultima sincronizzazione: 2025-08-20
Capitalizzazione di mercato
$213.06M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia CARGO Therapeutics, Inc. Common Stock (CRGX)

Categoria

Storico del prezzo dell'azione per CARGO Therapeutics, Inc. Common Stock (CRGX)
Prezzo di chiusura più alto: $4.48 il 2025-08-01

Prezzo di chiusura più basso: $14.85 il 2023-11-01
Storico del prezzo dell'azione di CARGO Therapeutics, Inc. Common Stock dal 2023 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2025 -71.01%
2024 -16.24%
2023 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$122.66 -9.24%
AU
$757.71 6.76%
CH